Molecular cloning and characterization of a novel anti-TLR9 intrabody.

Item

http://www.wikidata.org/entity/Q39119214

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Molecular cloning and characterization of a novel anti-TLR9 intrabody.

@en

Molecular cloning and characterization of a novel anti-TLR9 intrabody.

@nl

type

Item

label

Molecular cloning and characterization of a novel anti-TLR9 intrabody.

@en

Molecular cloning and characterization of a novel anti-TLR9 intrabody.

@nl

prefLabel

Molecular cloning and characterization of a novel anti-TLR9 intrabody.

@en

Molecular cloning and characterization of a novel anti-TLR9 intrabody.

@nl

P1476

Molecular cloning and characterization of a novel anti-TLR9 intrabody

@en

P2093

Alina Fels

http://www.w3.org/2001/XMLSchema#string

Carsten J Kirschning

http://www.w3.org/2001/XMLSchema#string

Diana Zegenhagen

http://www.w3.org/2001/XMLSchema#string

Elisa Reimer

http://www.w3.org/2001/XMLSchema#string

Ludger Grosse Hovest

http://www.w3.org/2001/XMLSchema#string

Stefan Bauer

http://www.w3.org/2001/XMLSchema#string

Stefan Somplatzki

http://www.w3.org/2001/XMLSchema#string

Svenja Hänel

http://www.w3.org/2001/XMLSchema#string

Thomas Böldicke

http://www.w3.org/2001/XMLSchema#string

Thorsten Bollhorst

http://www.w3.org/2001/XMLSchema#string

P2860

A computational study of off-target effects of RNA interference

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

Pathogen recognition and innate immunity

Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation.

Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.

Functional inhibition of transitory proteins by intrabody-mediated retention in the endoplasmatic reticulum.

Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.

Toll-like receptors in systemic autoimmune disease.

Progress and problems with the use of viral vectors for gene therapy.

Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER.

P2888

s11658-013-0098-8

P304

433-446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2478/S11658-013-0098-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

253335517

http://www.w3.org/2001/XMLSchema#string

P6179

1006147617

http://www.w3.org/2001/XMLSchema#string

P698

23893288

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

6275677

http://www.w3.org/2001/XMLSchema#string